Genprex(GB:0A8I)
$2.20-0.22 (-9.09%)
GB:0A8I
Genprex stock analysis
$2.20
At close:-0.22 (-9.09%)
Genprex (0A8I) Share Price & Analysis
0 Followers
0A8I Stock Chart & Stats
$2.20-$0.22(-9.09%)
At close: 4:30 PM GMT
- Day’s Range
- $2.20 - $2.34
- 52-Week Range
- $1.75 - $104.29
- Previous Close
- $2.42
- Volume
- N/A
- Average Volume (3M)
- 1,113
- Market Cap
- $1.88M
- Enterprise Value
- -$17.26T
- Total Cash (Recent Filing)
- $15.15M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- ―
- Beta
- -0.85
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Genprex News
0A8I FAQ
What was Genprex’s price range in the past 12 months?
Genprex lowest share price was $1.75 and its highest was $104.29 in the past 12 months.
What is Genprex’s market cap?
Genprex’s market cap is $1.88M.
When is Genprex’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genprex’s earnings last quarter?
Genprex released its earnings results on Aug 13, 2019. The company reported -$0.236 earnings per share for the quarter.
Is Genprex overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Genprex pay dividends?
Genprex does not currently pay dividends.
What is Genprex’s EPS estimate?
Genprex’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genprex have?
Genprex has 819,709 shares outstanding.
What happened to Genprex’s price movement after its last earnings report?
Genprex reported an EPS of -$0.236 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Genprex?
Currently, no hedge funds are holding shares in GB:0A8I
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genprex
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ryan Confer
- Employees
- 13
- Website
- www.genprex.com
- Address
- 3300 Bee Cave Road, Austin, TX, 78746, US
Genprex (0A8I) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 5 | 9 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 4 | 0 | 8 |
